| 摘要 |
<p>In general, the invention is directed to systems and techniques for assessing a risk of ventricular tachyarrhythmia in a patient by measuring one or more biochemical markers that reflect the health of a patient. Typically, the patient submits a sample, such as a blood sample, which is tested for one or more biomarkers. Based upon the results of the tests, the patient's risk of ventricular tachyarrhythmia may be assessed. When the patient is found to be at risk, the patient may receive an implantable medical device or drug therapy to address the risk.</p> |
| 申请人 |
MEDTRONIC, INC.;SOYKAN, ORHAN;ROBINSON, TIMOTHY, H.;OLSON, WALTER, H.;SHARMA, VINROD;DEARKING, AMY, C. |
发明人 |
SOYKAN, ORHAN;ROBINSON, TIMOTHY, H.;OLSON, WALTER, H.;SHARMA, VINROD;DEARKING, AMY, C. |
